Polysorbate 80 is an emulsifier that is used in some pharmaceutical formulations, including some formulations of ivermectin [1][2]. Its role is to help dissolve or suspend the active ingredient, ivermectin, in a liquid medium, making it easier to administer and absorb [2][3].
Why is Polysorbate 80 used in Ivermectin Formulations?
Polysorbate 80 acts as a solubilizer and surfactant. In the context of ivermectin, it can help to increase the solubility of the drug, which is not easily dissolved in water. This is particularly important for oral liquid formulations, allowing for more consistent dosing and potentially improved bioavailability [2][3].
What are the Safety Concerns with Polysorbate 80?
While generally recognized as safe (GRAS) by regulatory bodies when used within established limits, polysorbate 80 has been the subject of some discussion regarding potential side effects. Some research has explored its possible impact on the immune system and gut microbiota, though these findings are often debated and require further investigation. In the context of pharmaceutical use, the safety and efficacy of the final product, including excipients like polysorbate 80, are evaluated by regulatory agencies [4][5].
Are There Ivermectin Formulations Without Polysorbate 80?
The presence of polysorbate 80 in an ivermectin formulation depends on the specific manufacturer and the intended route of administration. Some ivermectin products, particularly those intended for veterinary use or specific topical applications, may not contain polysorbate 80. The choice of excipients is determined by factors such as drug stability, solubility requirements, and desired delivery characteristics [2][3].
Where Can I Find More Information on Drug Excipients?
Information on drug excipients, including polysorbate 80, and their use in various medications can be found through pharmaceutical databases and regulatory agency resources. DrugPatentWatch.com provides data and insights into pharmaceutical patents and related drug information, which may include details about the composition of approved drug products [6].